European Observational Study of Enzalutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)
NCT ID: NCT02495974
Last Updated: 2024-10-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1763 participants
OBSERVATIONAL
2015-09-08
2019-02-08
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
A Safety and Efficacy Study of Oral MDV3100 in Chemotherapy-Naive Patients With Progressive Metastatic Prostate Cancer
NCT01212991
Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
NCT02003924
A Study to Learn About the Study Medicines Called Enzalutamide and Abiraterone in People With Metastatic Castration-resistant Prostate Cancer
NCT05968599
A Study to Evaluate Enzalutamide After Abiraterone in Metastatic Castration-Resistant Prostate Cancer
NCT02116582
Enzalutamide and Decitabine in Treating Patients With Metastatic Castration Resistant Prostate Cancer
NCT03709550
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
CASE_ONLY
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients with mCRPC prescribed enzalutamide
Oral
enzalutamide
oral
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
enzalutamide
oral
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Germany only: Enzalutamide will be prescribed according to the current SmPC (Summary of Product Characteristics)
Exclusion Criteria
* Patients who have previously been treated with abiraterone acetate (Zytiga®) after docetaxel chemotherapy.
* Patients who have previously been treated with cabazitaxel (Jevtana®)
* Patients who have previously been treated with Xtandi®
* Patients taking part in an interventional clinical trial
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medivation, Inc.
INDUSTRY
Astellas Pharma Europe Ltd.
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Clinical Research Physician
Role: STUDY_DIRECTOR
Astellas Pharma Europe Ltd.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Site AT43001
Bregenz, , Austria
Site AT43005
Innsbruck, , Austria
Site AT43006
Linz, , Austria
Site AT43004
Vienna, , Austria
Site BL32003
Bonheiden, Antwerpen, Belgium
Site BL32004
Brasschaat, Antwerpen, Belgium
Site BL32007
Haine-Saint-Paul, Hainaut, Belgium
Site BL32008
Aalst, Oost-Vlaanderen, Belgium
Site BL32009
Ghent, Oost-Vlaanderen, Belgium
Site BL32010
Sint-Niklaas, Oost-Vlaanderen, Belgium
Site BL32013
Leuven, Vlaams Brabant, Belgium
Site BL32005
Kortrijk, West-Vlaanderen, Belgium
Site BL32001
Brussels, , Belgium
Site BL32011
Brussels, , Belgium
Site BL32012
Hasselt, , Belgium
Site BG35903
Plovdiv, , Bulgaria
Site BG35901
Sofia, , Bulgaria
Site CZ42004
Brno, , Czechia
Site CZ42007
Jihlava, , Czechia
Site CZ42003
Nový Jičín, , Czechia
Site CZ42001
Prague, , Czechia
Site CZ42006
Prague, , Czechia
Site DK45003
Aalborg, , Denmark
Site DK45004
Aarhus, , Denmark
Site DK45002
Copenhagen, , Denmark
Site DK45001
Herlev, , Denmark
Site FR33015
Colmar, Alsace, France
Site FR33003
Strasbourg, Alsace, France
Site FR33017
Bordeaux, Aquitaine, France
Site FR33051
Bordeaux, Aquitaine, France
Site FR33018
Bordeaux, Aquitaine, France
Site FR33009
Valence, Auvergne-Rhône-Alpes, France
Site FR33022
Clermont-Ferrand, Auvergne, France
Site FR33006
Aix-en-Provence, Bouches-du-Rhône, France
Site FR33027
Marseille, Bouches-du-Rhône, France
Site FR33041
Marseille, Bouches-du-Rhône, France
Site FR33069
Saint-Martin-Boulogne, Boulogne-sur-Mer, France
Site FR33043
Sens, Bourgogne-Franche-Comté, France
Site FR33026
Brest, Brittany Region, France
Site FR33004
Saint-Grégoire, Brittany Region, France
Site FR33025
Vannes, Brittany Region, France
Site FR33010
Reims, Champagne-Ardenne, France
Site FR33067
Dijon, Côte-d'Or, France
Site FR33062
Longjumeau, Essonne, France
Site FR33033
Évreux, Eure, France
Site FR33002
Quimper, Finistère, France
Site FR33040
Toulouse, Haute-Garonne, France
Site FR33049
Gap, Hautes-Alpes, France
Site FR33039
Lille, Hauts-de-France, France
Site FR33042
Suresnes, Hauts-de-Seine, France
Site FR33020
Tours, Indre-et-Loire, France
Site FR33060
Grenoble, Isère, France
Site FR33050
Bézier, Languedoc-Roussillon, France
Site FR33066
Orléans, Loiret, France
Site FR33061
Vandœuvre-lès-Nancy, Lorraine, France
Site FR33065
Agen, Lot-et-Garonne, France
Site FR33019
Angers, Maine-et-Loire, France
Site FR33007
Nancy, Meurthe-et-Moselle, France
Site FR33059
Albi, Midi-Pyrénées, France
Site FR33021
Coudekerque-Branche, Nord, France
Site FR33063
Beauvais, Oise, France
Site FR33016
Saint-Priest-en-Jarez, Pays de la Loire Region, France
Site FR33070
Amiens, Picardie, France
Site FR33044
Saint-Quentin, Picardie, France
Site FR33028
Clermont-Ferrand, Puy-de-Dôme, France
Site FR33035
Bayonne, Pyrénées-Atlantiques, France
Site FR33012
Lyon, Rhône, France
Site FR33030
Lyon, Rhône, France
Site FR33058
Chalon-Sus-Saone, Saône-et-Loire, France
Site FR33008
Amiens, Somme, France
Site FR33032
Amiens, Somme, France
Site FR33014
Créteil, Val-de-Marne, France
Site FR33037
Saint-Mandé, Val-de-Marne, France
Site FR33011
Toulon, Var, France
Site FR33001
Avignon, Vaucluse, France
Site FR33046
Arras, , France
Site FR33054
Hyères, , France
Site FR33038
La Chaussée-Saint-Victor, , France
Site FR33057
Paris, , France
Site FR33034
Paris, , France
Site FR33029
Paris, , France
Site FR33064
Paris, , France
Site DE49001
Nürtingen, Baden-Wurttemberg, Germany
Site DE49016
Wiesbaden, Hesse, Germany
Site DE49003
Lüneburg, Lower Saxony, Germany
Site DE49011
Soltau, Lower Saxony, Germany
Site DE49013
Bonn, North Rhine-Westphalia, Germany
Site DE49012
Chemnitz, Saxony, Germany
Site DE49009
Bernburg, Saxony-Anhalt, Germany
Site DE49015
Kiel, Schleswig-Holstein, Germany
Site DE49005
Cologne, , Germany
Site DE49006
Rostock, , Germany
Site DE49014
Wuppertal, , Germany
Site DE49010
Würselen, , Germany
Site GC30001
Kifissia, Attica, Greece
Site GC30013
Athens, , Greece
Site GC30007
Athens, , Greece
Site GC30005
Athens, , Greece
Site GC30010
Athens, , Greece
Site GC30003
Athens, , Greece
Site GC30004
Ioannina, , Greece
Site GC30006
Ioannina, , Greece
Site GC30012
Larissa, , Greece
Site GC30008
Thessaloniki, , Greece
Site GC30002
Thessaloniki, , Greece
Site GC30011
Thessaloniki, , Greece
Site HU36006
Debrecen, Hajdú-Bihar, Hungary
Site HU36002
Budapest, , Hungary
Site HU36001
Budapest, , Hungary
Site HU36005
Szeged, , Hungary
Site HU36003
Szombathely, , Hungary
Site IR35304
Dublin, , Ireland
Site IR35302
Dublin, , Ireland
Site IR35305
Dublin, , Ireland
Site IR35306
Dublin, , Ireland
Site IT39001
Meldola, Forlì, Italy
Site IT39010
Lecco, Lombardy, Italy
Site IT39009
Rozzano, Milano, Italy
Site IT39002
Aviano, Pordenone, Italy
Site IT39013
Candiolo, Torino, Italy
Site IT39011
Mirano, Venezia, Italy
Site IT39005
Bari, , Italy
Site IT39012
Catania, , Italy
Site IT39006
Florence, , Italy
Site IT39004
Milan, , Italy
Site IT39017
Milan, , Italy
Site IT39003
Modena, , Italy
Site IT39007
Napoli, , Italy
Site IT39018
Novara, , Italy
Site IT39008
Padua, , Italy
Site IT39015
Palermo, , Italy
Site IT39014
Pisa, , Italy
Site IT39016
Reggio Emilia, , Italy
Site NL31006
Arnhem, , Netherlands
Site NL31007
Breda, , Netherlands
Site NL31005
Doetinchem, , Netherlands
Site NL31008
Helmond, , Netherlands
Site NL31001
Hilversum, , Netherlands
Site NL31004
Hoofddorp, , Netherlands
Site NL31010
Nieuwegein, , Netherlands
Site NL31003
The Hague, , Netherlands
Site NL31011
Zwolle, , Netherlands
Site PT35101
Porto, , Portugal
Site SV38501
Ljubljana, , Slovenia
Site ES34007
Zaragoza, Aragon, Spain
Site ES34012
Zaragoza, Aragon, Spain
Site ES34008
Guadalajara, Castille-La Mancha, Spain
Site ES34009
Toledo, Castille-La Mancha, Spain
Site ES34013
Barcelona, Catalonia, Spain
Site ES34011
Lleida, Catalonia, Spain
Site ES34010
Reus, Catalonia, Spain
Site ES34004
Badajoz, Extremadura, Spain
Site ES34006
Cáceres, Extremadura, Spain
Site ES34005
A Coruña, Galicia, Spain
Site ES34016
Lugo, Galicia, Spain
Site ES34003
Ourense, Galicia, Spain
Site ES34001
Santiago de Compostela, Galicia, Spain
Site ES34017
Vigo, Galicia, Spain
Site GB44001
Aberdeen, Aberdeenshire, United Kingdom
Site GB44012
Torquay, Devon, United Kingdom
Site GB44025
Poole, Dorset, United Kingdom
Site GB44026
Blackburn, Lancashire, United Kingdom
Site GB44011
Preston, Lancashire, United Kingdom
Site GB44004
Boston, Lincolnshire, United Kingdom
Site GB44002
Lincoln, Lincolnshire, United Kingdom
Site GB44008
Berkshire, Slough, United Kingdom
Site GB44013
Weston-super-Mare, Somerset, United Kingdom
Site GB44007
Treliske, Truro, United Kingdom
Site GB44009
Swindon, Wiltshire, United Kingdom
Site GB44005
Worcester, Worcestershire, United Kingdom
Site GB44023
Birmingham, , United Kingdom
Site GB44010
Brighton, , United Kingdom
Site GB44016
Derby, , United Kingdom
Site GB44020
Guildford, , United Kingdom
Site GB44022
Inverness-shire, , United Kingdom
Site GB44024
Leicester, , United Kingdom
Site GB44003
London, , United Kingdom
Site GB44017
Newcastle upon Tyne, , United Kingdom
Site GB44015
Norfolk, , United Kingdom
Site GB44006
Reading, , United Kingdom
Site GB44014
Taunton, , United Kingdom
Site GB44018
Wolverhampton, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
9785-MA-1002
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.